Patiromer: all 25 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Patiromer and Diet/hrQoL in Chronic DialysisRecruitingNCT06858280Phase 3
- Potassium Correction for RAAS Optimization in Chronic Kidney DiseaseRecruitingNCT06256991Phase 4
- Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium LevelsRecruitingNCT05766839Phase 2
- Comparison of Potassium Binders in the ERTerminatedNCT04585542Phase 4Results posted
- RELieving Increasing oEdema Due to Heart FailureTerminatedNCT04142788Phase 4Results posted
- Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)CompletedNCT03888066Phase 3Results posted
- Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease PatientsCompletedNCT03781089Phase 4Results posted
- A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney DiseaseCompletedNCT03740048Phase 3Results posted
- The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With HyperkalemiaCompletedNCT03326583Phase 2Results posted
- Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.CompletedNCT03183778Phase 4Results posted
- Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and HyperkalemiaTerminatedNCT03087058Phase 2Results posted
- Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney DiseaseCompletedNCT03071263Phase 2Results posted
- Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)CompletedNCT02933450Phase 4Results posted
- Patiromer With or Without Food for the Treatment of HyperkalemiaCompletedNCT02694744Phase 4Results posted
- An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on HemodialysisTerminatedNCT02033317Phase 2Results posted
- A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)CompletedNCT01810939Phase 3Results posted
- Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)CompletedNCT01371747Phase 2Results posted
- Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney DiseaseCompletedNCT01130597Phase 2Results posted
- Evaluation of Patiromer in Heart Failure PatientsCompletedNCT00868439Phase 2Results posted
- Patiromer Trial in CKD Stage IIIB to VTerminatedNCT05786469Phase 3
- Trial Evaluating the Efficacy and Safety of Patiromer in Chinese SubjectsCompletedNCT05136664Phase 3
- Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant RecipientsCompletedNCT05029310Phase 4
- Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia ManagementTerminatedNCT04443608Phase 4
- Exploratory Study of ZG-801 for the Treatment of HyperkalemiaCompletedNCT03799926Phase 2
- Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving PatiromerCompletedNCT03229265Phase 4